着床前診断をめぐるスイスの動向 [in Japanese] Recent trends in legal regulations on preimplantation genetic diagnosis in Switzerland [in Japanese]
Access this Article
Search this Article
In this study, I analyze a process of lifting the ban on the preimplantation genetic diagnosis (PGD) in Switzerland. The Swiss Reproductive Medicine Act, constituted in 1998 and put into force in 2001, has prohibited PGD. However, the legislative situation with regard to bioethical problems has changed in recent years. The abortion has been legalized by a revision of the criminal law in 2001, and the creation of human embryonic stem cells has been permitted by the Stem Cell Research Act in 2003. In 2005, the Swiss Parliament carried a motion demanding that the federal Council of Ministers lift the ban on PGD by revising the Reproductive Medicine Act. PGD is criticized for leading to eugenics or discrimination against disabled persons. It is prohibited in Germany, Austria, and Italy, while it is accepted in the UK, France, Japan, and many other countries. Switzerland, like Germany, has strict regulations on reproductive medicine, but differs from Germany with respect to the grounds for the ban on PGD. In Germany, the research into an embryo including PGD is prohibited on the ground that an embryo has the dignity of a person; on the other hand, in Switzerland, PGD is prohibited on the ground that side effects on an examined embryo or the influence on society is not clear. In other words, in Switzerland, the ban on PGD is not based on a fundamental principle. I explain these discussions about PGD through the records of the Swiss Parliament and the opinion of the Swiss National Advisory Commission on Biomedical Ethics.
- Research reports of Fukui National College of Technology Humanities and social science
Research reports of Fukui National College of Technology Humanities and social science (41), 1-11, 2007-11
Fukui National College of Technology